| http://www.w3.org/ns/prov#value | - assessment of treatment tolerability measured by adverse events such as grade 4 toxicities, hospitalizations for toxicities, fever and neutropenia events and clinically significant bleeding/thrombotic events [ Time Frame: will document all adverse experiences after the start of the study and will follow up subjects until event has disappeared or condition stabilized ] [ Designated as safety issue:
|
